Vaxcyte, Inc. — Director's Dealing 2020

Jun 12, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2020-06-11

Reporting Person: Gilbert Halley E (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$5.35	2030-04-17	Common Stock (78948)		Direct

Footnotes

F1: 1/3 of the shares subject to the option vest on April 24, 2021, and 1/36 of the shares vest monthly thereafter.